Anti-tuberculosis drug resistance in the world.
Material type: TextPublication details: Geneva : World Health Organization, 2004. Description: 299 p. : ill. ; 24 cmISBN: 9241562854Subject(s): Tuberculosis | Drug resistance | Tuberculosis, Multidrug-Resistant | Tuberculosis, Multidrug-ResistantNLM classification: WF 360 A 2004Summary: This is the third report of the WHO/IUATLD project which gives comparable worldwide information on anti-tuberculosis drug resistance, with data from surveys conducted in 77 different countries or geographical settings during the years 1999 to 2002. Global surveillance identifies areas of high resistance and draws the attention of national authorities to address the problems involved. The report also highlights the importance of conducting surveillance on re-treatment cases, and the role of the laboratory in TB control.Item type | Current library | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|
WHO Publications | FNPH LIBRARY | WF 360 A 2004 (Browse shelf(Opens below)) | Available | 03345 |
Browsing FNPH LIBRARY shelves Close shelf browser (Hides shelf browser)
No cover image available | No cover image available | |||||||
WF 310 R 2011 Regional response plan for programmatic management of drug-resistant tuberculosis : | WF 310 T 2003 Tuberculosis. | WF 360 A 2002 A guide for tuberculosis treatment supporters. | WF 360 A 2004 Anti-tuberculosis drug resistance in the world. | WF 360 A 2008 Anti-tuberculosis drug resistance in the world : | WF 360 A 2008 Anti-tuberculosis drug resistance in the world : | WF 360 A 2008 Anti-tuberculosis drug resistance in the world : |
This is the third report of the WHO/IUATLD project which gives comparable worldwide information on anti-tuberculosis drug resistance, with data from surveys conducted in 77 different countries or geographical settings during the years 1999 to 2002. Global surveillance identifies areas of high resistance and draws the attention of national authorities to address the problems involved. The report also highlights the importance of conducting surveillance on re-treatment cases, and the role of the laboratory in TB control.
There are no comments on this title.